0925224a-figure-01 (0925224a Figure 01)
Ropinirole Tablet, Extended Release
Product Images NDC 43547-554
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ropinirole (NDC 43547-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
2 mg 30 Tablets (0925224a Figure 02)
Each tablet of the medicine contains 228 mg of ropiniole HC that is equivalent to 0.2 mg of opiniol. The usual dosage can be found in the prescribing information for complete dosing instructions. The medicine should be kept in a tightly sealed, child-resistant container. Extended release tablets should be stored at 16°C to 30°C (59F to 86°F). The medicine is manufactured by S Zveens Hahai Pharmaceutical Co., Ltd. and distributed by PARMACET Depercs e Por Fiion. Patient information regarding the medicine can be found at the given website.*
4 mg 30 Tablets (0925224a Figure 03)
6 mg 30 Tablets (0925224a Figure 04)
8 mg 30 Tablets (0925224a Figure 05)
12 mg 30 Tablets (0925224a Figure 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
